LEADER 02919oam 2200577I 450 001 9910823019003321 005 20240314024459.0 010 $a0-429-16843-8 010 $a1-4665-8714-8 024 7 $a10.1201/b15301 035 $a(CKB)2670000000394615 035 $a(EBL)1335842 035 $a(OCoLC)855504706 035 $a(SSID)ssj0000876664 035 $a(PQKBManifestationID)11535867 035 $a(PQKBTitleCode)TC0000876664 035 $a(PQKBWorkID)10923356 035 $a(PQKB)10353397 035 $a(OCoLC)857081231 035 $a(MiAaPQ)EBC1335842 035 $a(OCoLC)853508638 035 $a(EXLCZ)992670000000394615 100 $a20180331d2014 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aBiomarkers in cardiovascular diseases /$feditors, Dimitris Tousoulis, Christodoulos Stefanadis 205 $a1st ed. 210 1$aBoca Raton :$cCRC Press,$d2014. 215 $a1 online resource (450 p.) 300 $aDescription based upon print version of record. 311 $a1-4665-8715-6 320 $aIncludes bibliographical references and index. 327 $apt. 1. Classical biomarkers -- pt. 2. Novel biomarkers. 330 $aThe establishment of precise and reliable biomarker tests for the early stages of cardiovascular disease is of great importance and can be the cornerstone in the prevention of future cardiovascular disease (CVD). Furthermore, some biomarkers may provide important information concerning the pathogenesis of CVD or appear to be useful in risk stratification, in CVD diagnosis, or in monitoring therapy; many others may be risk factors themselves, representing therefore potential targets of therapy. The ideal biomarker should have the following characteristics: highly sensitive, specific, reliable, accessible, standardized, dependable, cost effective, and easily interpretable by clinicians. The present book focuses on the presentation and evaluation of the most promising classical and novel biochemical markers used in CVD (coronary artery disease, hypertension, heart failure, hyperlipidemia, peripheral arterial disease). The underlying pathophysiological characteristics of each biomarker, as well as potential clinical implications in daily practice are reviewed in this book--Provided by publisher. 606 $aCardiovascular system$xDiseases$xDiagnosis 606 $aCardiovascular system$xDiseases$xPrevention 615 0$aCardiovascular system$xDiseases$xDiagnosis. 615 0$aCardiovascular system$xDiseases$xPrevention. 676 $a616.1075 701 $aTousoulis$b Dimitris$0897327 701 $aStefanadis$b Christodoulos$01600452 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910823019003321 996 $aBiomarkers in cardiovascular diseases$93923551 997 $aUNINA